The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
Methylphenidate (MPH) is a stimulant drug and an effective treatment for attention-deficit/hyperactivity disorder (ADHD) in both children and adults. Pre-clinical studies suggest that the response to stimulants is dependent on age, which may reflect the ontogeny of the dopamine (DA) system, which co...
Main Authors: | A Schrantee, HJMM Mutsaerts, C Bouziane, HGH Tamminga, MA Bottelier, L Reneman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | NeuroImage: Clinical |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213158216302297 |
Similar Items
-
Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
by: David D. Kaminester
Published: (2020-12-01) -
A Quasi-Experimental Trial in Comparison of Duloxetine and Methylphenidate in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder
by: Nasrin Dodangi, et al.
Published: (2016-06-01) -
Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
by: Lee H, et al.
Published: (2020-05-01) -
Effect of one-month treatment with methylphenidate on salivary cortisol level of attention deficit hyperactivity disorder children
by: Esraa Yahia Kholif, et al.
Published: (2021-03-01) -
Methylphenidate does not affect convergent and divergent creative processes in healthy adults
by: Matthijs Baas, et al.
Published: (2020-01-01)